Early progression in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) vs placebo (P) Meeting Abstract


Authors: Reinacher-Schick, A.; Macarulla, T.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Tortora, G.; Algül, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G. Y.; Golan, T.
Abstract Title: Early progression in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) vs placebo (P)
Meeting Title: 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 4
Meeting Dates: 2020 Oct 9-11
Meeting Location: Virtual
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-10-01
Start Page: 218
End Page: 219
Language: English
ACCESSION: WOS:000575955000491
PROVIDER: wos
DOI: 10.1159/000510995
Notes: Meeting Abstract: 639 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly